 | • レポートコード：QY2108PAL4060 • 出版社/出版日：QYResearch / 2021年8月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、114ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品 |
| Single User | ￥735,000 (USD4,900) | ▷ お問い合わせ |
| Multi User | ￥1,102,500 (USD7,350) | ▷ お問い合わせ |
| Enterprise License | ￥1,470,000 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査資料はフルニキシンメグルミン注射の世界市場の現状について調査・分析し、2027年までの市場を予測しました。フルニキシンメグルミン注射の世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（10ml /用量、20ml /用量）、用途別市場規模（動物筋肉痛、動物発熱性疾患、その他）、主要地域別市場規模（北米・アメリカ、ヨーロッパ、アジア・日本・中国・インド、中南米、中東・アフリカ）、関連企業の情報、バリューチェーン・販売チャネル、市場動向などを収録しています。 ・フルニキシンメグルミン注射の世界市場概要 ・メーカー別の競争状況、市場シェア ・フルニキシンメグルミン注射の種類別市場規模：10ml /用量、20ml /用量 ・フルニキシンメグルミン注射の用途別市場規模：動物筋肉痛、動物発熱性疾患、その他 ・北米のフルニキシンメグルミン注射市場規模2016-2027：種類別、用途別、国別（アメリカ、カナダ） ・ヨーロッパのフルニキシンメグルミン注射市場規模2016-2027：種類別、用途別、国別（ドイツ、フランス、イギリス） ・アジアのフルニキシンメグルミン注射市場規模2016-2027：種類別、用途別、国別（日本、中国、インド、韓国） ・中南米のフルニキシンメグルミン注射市場規模2016-2027：種類別、用途別、国別（メキシコ、ブラジル） ・中東・アフリカのフルニキシンメグルミン注射市場規模2016-2027：種類別、用途別、国別（トルコ、サウジアラビア） ・企業情報：Norbrook、Zoteis、Merck Animal Health、Virbac Animal Health India Private Limited、MSD Animal Health、Bengal Remedies Limited、Wuhan Huisheng Biological Technology Co., Ltd.、Qilu Animal Health Products Co., Ltd.、Baimukang Animal Pharmaceutical Co., Ltd.、Shandong Zhongmu Veterinary Medicine Co., Ltd.、Hebei New Century Pharmaceutical Co., Ltd.、Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd.、Shandong Lukang Pharmaceutical Co., Ltd. ・フルニキシンメグルミン注射のバリューチェーン・販売チャネル分析 ・フルニキシンメグルミン注射の世界市場動向 |
Flunixin Meglumine Injection is used for febrile diseases, muscle pain and soft tissue pain of livestock and small animals
Market Analysis and Insights: Global Flunixin Meglumine Injection Market
The global Flunixin Meglumine Injection market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027.
Global Flunixin Meglumine Injection Scope and Segment
Flunixin Meglumine Injection market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Flunixin Meglumine Injection market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.
Segment by Type
10ml/Dose
20ml/ Dose
Segment by Application
Animal muscle pain
Animal febrile disease
Others
By Company
Norbrook
Zoteis
Merck Animal Health
Virbac Animal Health India Private Limited
MSD Animal Health
Bengal Remedies Limited
Wuhan Huisheng Biological Technology Co., Ltd.
Qilu Animal Health Products Co., Ltd.
Baimukang Animal Pharmaceutical Co., Ltd.
Shandong Zhongmu Veterinary Medicine Co., Ltd.
Hebei New Century Pharmaceutical Co., Ltd.
Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd.
Shandong Lukang Pharmaceutical Co., Ltd.
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
1 Study Coverage
1.1 Flunixin Meglumine Injection Product Introduction
1.2 Market by Type
1.2.1 Global Flunixin Meglumine Injection Market Size Growth Rate by Type
1.2.2 10ml/Dose
1.2.3 20ml/ Dose
1.3 Market by Application
1.3.1 Global Flunixin Meglumine Injection Market Size Growth Rate by Application
1.3.2 Animal muscle pain
1.3.3 Animal febrile disease
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Flunixin Meglumine Injection Sales Estimates and Forecasts 2016-2027
2.2 Global Flunixin Meglumine Injection Revenue Estimates and Forecasts 2016-2027
2.3 Global Flunixin Meglumine Injection Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Flunixin Meglumine Injection Regions by Sales
2.4.1 Global Top Flunixin Meglumine Injection Regions by Sales (2016-2021)
2.4.2 Global Top Flunixin Meglumine Injection Regions by Sales (2022-2027)
2.5 Global Top Flunixin Meglumine Injection Regions by Revenue
2.5.1 Global Top Flunixin Meglumine Injection Regions by Revenue (2016-2021)
2.5.2 Global Top Flunixin Meglumine Injection Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Flunixin Meglumine Injection Sales by Manufacturers
3.1.1 Global Top Flunixin Meglumine Injection Manufacturers by Sales (2016-2021)
3.1.2 Global Top Flunixin Meglumine Injection Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Flunixin Meglumine Injection Sales in 2020
3.2 Global Flunixin Meglumine Injection Revenue by Manufacturers
3.2.1 Global Top Flunixin Meglumine Injection Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Flunixin Meglumine Injection Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Flunixin Meglumine Injection Revenue in 2020
3.3 Global Flunixin Meglumine Injection Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Flunixin Meglumine Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Flunixin Meglumine Injection Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Flunixin Meglumine Injection Sales by Type
4.1.1 Global Flunixin Meglumine Injection Historical Sales by Type (2016-2021)
4.1.2 Global Flunixin Meglumine Injection Forecasted Sales by Type (2022-2027)
4.1.3 Global Flunixin Meglumine Injection Sales Market Share by Type (2016-2027)
4.2 Global Flunixin Meglumine Injection Revenue by Type
4.2.1 Global Flunixin Meglumine Injection Historical Revenue by Type (2016-2021)
4.2.2 Global Flunixin Meglumine Injection Forecasted Revenue by Type (2022-2027)
4.2.3 Global Flunixin Meglumine Injection Revenue Market Share by Type (2016-2027)
4.3 Global Flunixin Meglumine Injection Price by Type
4.3.1 Global Flunixin Meglumine Injection Price by Type (2016-2021)
4.3.2 Global Flunixin Meglumine Injection Price Forecast by Type (2022-2027)
5 Market Size by Application
5.1 Global Flunixin Meglumine Injection Sales by Application
5.1.1 Global Flunixin Meglumine Injection Historical Sales by Application (2016-2021)
5.1.2 Global Flunixin Meglumine Injection Forecasted Sales by Application (2022-2027)
5.1.3 Global Flunixin Meglumine Injection Sales Market Share by Application (2016-2027)
5.2 Global Flunixin Meglumine Injection Revenue by Application
5.2.1 Global Flunixin Meglumine Injection Historical Revenue by Application (2016-2021)
5.2.2 Global Flunixin Meglumine Injection Forecasted Revenue by Application (2022-2027)
5.2.3 Global Flunixin Meglumine Injection Revenue Market Share by Application (2016-2027)
5.3 Global Flunixin Meglumine Injection Price by Application
5.3.1 Global Flunixin Meglumine Injection Price by Application (2016-2021)
5.3.2 Global Flunixin Meglumine Injection Price Forecast by Application (2022-2027)
6 North America
6.1 North America Flunixin Meglumine Injection Market Size by Type
6.1.1 North America Flunixin Meglumine Injection Sales by Type (2016-2027)
6.1.2 North America Flunixin Meglumine Injection Revenue by Type (2016-2027)
6.2 North America Flunixin Meglumine Injection Market Size by Application
6.2.1 North America Flunixin Meglumine Injection Sales by Application (2016-2027)
6.2.2 North America Flunixin Meglumine Injection Revenue by Application (2016-2027)
6.3 North America Flunixin Meglumine Injection Market Size by Country
6.3.1 North America Flunixin Meglumine Injection Sales by Country (2016-2027)
6.3.2 North America Flunixin Meglumine Injection Revenue by Country (2016-2027)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Flunixin Meglumine Injection Market Size by Type
7.1.1 Europe Flunixin Meglumine Injection Sales by Type (2016-2027)
7.1.2 Europe Flunixin Meglumine Injection Revenue by Type (2016-2027)
7.2 Europe Flunixin Meglumine Injection Market Size by Application
7.2.1 Europe Flunixin Meglumine Injection Sales by Application (2016-2027)
7.2.2 Europe Flunixin Meglumine Injection Revenue by Application (2016-2027)
7.3 Europe Flunixin Meglumine Injection Market Size by Country
7.3.1 Europe Flunixin Meglumine Injection Sales by Country (2016-2027)
7.3.2 Europe Flunixin Meglumine Injection Revenue by Country (2016-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Flunixin Meglumine Injection Market Size by Type
8.1.1 Asia Pacific Flunixin Meglumine Injection Sales by Type (2016-2027)
8.1.2 Asia Pacific Flunixin Meglumine Injection Revenue by Type (2016-2027)
8.2 Asia Pacific Flunixin Meglumine Injection Market Size by Application
8.2.1 Asia Pacific Flunixin Meglumine Injection Sales by Application (2016-2027)
8.2.2 Asia Pacific Flunixin Meglumine Injection Revenue by Application (2016-2027)
8.3 Asia Pacific Flunixin Meglumine Injection Market Size by Region
8.3.1 Asia Pacific Flunixin Meglumine Injection Sales by Region (2016-2027)
8.3.2 Asia Pacific Flunixin Meglumine Injection Revenue by Region (2016-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Flunixin Meglumine Injection Market Size by Type
9.1.1 Latin America Flunixin Meglumine Injection Sales by Type (2016-2027)
9.1.2 Latin America Flunixin Meglumine Injection Revenue by Type (2016-2027)
9.2 Latin America Flunixin Meglumine Injection Market Size by Application
9.2.1 Latin America Flunixin Meglumine Injection Sales by Application (2016-2027)
9.2.2 Latin America Flunixin Meglumine Injection Revenue by Application (2016-2027)
9.3 Latin America Flunixin Meglumine Injection Market Size by Country
9.3.1 Latin America Flunixin Meglumine Injection Sales by Country (2016-2027)
9.3.2 Latin America Flunixin Meglumine Injection Revenue by Country (2016-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Flunixin Meglumine Injection Market Size by Type
10.1.1 Middle East and Africa Flunixin Meglumine Injection Sales by Type (2016-2027)
10.1.2 Middle East and Africa Flunixin Meglumine Injection Revenue by Type (2016-2027)
10.2 Middle East and Africa Flunixin Meglumine Injection Market Size by Application
10.2.1 Middle East and Africa Flunixin Meglumine Injection Sales by Application (2016-2027)
10.2.2 Middle East and Africa Flunixin Meglumine Injection Revenue by Application (2016-2027)
10.3 Middle East and Africa Flunixin Meglumine Injection Market Size by Country
10.3.1 Middle East and Africa Flunixin Meglumine Injection Sales by Country (2016-2027)
10.3.2 Middle East and Africa Flunixin Meglumine Injection Revenue by Country (2016-2027)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Norbrook
11.1.1 Norbrook Corporation Information
11.1.2 Norbrook Overview
11.1.3 Norbrook Flunixin Meglumine Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Norbrook Flunixin Meglumine Injection Product Description
11.1.5 Norbrook Recent Developments
11.2 Zoteis
11.2.1 Zoteis Corporation Information
11.2.2 Zoteis Overview
11.2.3 Zoteis Flunixin Meglumine Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Zoteis Flunixin Meglumine Injection Product Description
11.2.5 Zoteis Recent Developments
11.3 Merck Animal Health
11.3.1 Merck Animal Health Corporation Information
11.3.2 Merck Animal Health Overview
11.3.3 Merck Animal Health Flunixin Meglumine Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 Merck Animal Health Flunixin Meglumine Injection Product Description
11.3.5 Merck Animal Health Recent Developments
11.4 Virbac Animal Health India Private Limited
11.4.1 Virbac Animal Health India Private Limited Corporation Information
11.4.2 Virbac Animal Health India Private Limited Overview
11.4.3 Virbac Animal Health India Private Limited Flunixin Meglumine Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 Virbac Animal Health India Private Limited Flunixin Meglumine Injection Product Description
11.4.5 Virbac Animal Health India Private Limited Recent Developments
11.5 MSD Animal Health
11.5.1 MSD Animal Health Corporation Information
11.5.2 MSD Animal Health Overview
11.5.3 MSD Animal Health Flunixin Meglumine Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 MSD Animal Health Flunixin Meglumine Injection Product Description
11.5.5 MSD Animal Health Recent Developments
11.6 Bengal Remedies Limited
11.6.1 Bengal Remedies Limited Corporation Information
11.6.2 Bengal Remedies Limited Overview
11.6.3 Bengal Remedies Limited Flunixin Meglumine Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 Bengal Remedies Limited Flunixin Meglumine Injection Product Description
11.6.5 Bengal Remedies Limited Recent Developments
11.7 Wuhan Huisheng Biological Technology Co., Ltd.
11.7.1 Wuhan Huisheng Biological Technology Co., Ltd. Corporation Information
11.7.2 Wuhan Huisheng Biological Technology Co., Ltd. Overview
11.7.3 Wuhan Huisheng Biological Technology Co., Ltd. Flunixin Meglumine Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.7.4 Wuhan Huisheng Biological Technology Co., Ltd. Flunixin Meglumine Injection Product Description
11.7.5 Wuhan Huisheng Biological Technology Co., Ltd. Recent Developments
11.8 Qilu Animal Health Products Co., Ltd.
11.8.1 Qilu Animal Health Products Co., Ltd. Corporation Information
11.8.2 Qilu Animal Health Products Co., Ltd. Overview
11.8.3 Qilu Animal Health Products Co., Ltd. Flunixin Meglumine Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.8.4 Qilu Animal Health Products Co., Ltd. Flunixin Meglumine Injection Product Description
11.8.5 Qilu Animal Health Products Co., Ltd. Recent Developments
11.9 Baimukang Animal Pharmaceutical Co., Ltd.
11.9.1 Baimukang Animal Pharmaceutical Co., Ltd. Corporation Information
11.9.2 Baimukang Animal Pharmaceutical Co., Ltd. Overview
11.9.3 Baimukang Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.9.4 Baimukang Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product Description
11.9.5 Baimukang Animal Pharmaceutical Co., Ltd. Recent Developments
11.10 Shandong Zhongmu Veterinary Medicine Co., Ltd.
11.10.1 Shandong Zhongmu Veterinary Medicine Co., Ltd. Corporation Information
11.10.2 Shandong Zhongmu Veterinary Medicine Co., Ltd. Overview
11.10.3 Shandong Zhongmu Veterinary Medicine Co., Ltd. Flunixin Meglumine Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.10.4 Shandong Zhongmu Veterinary Medicine Co., Ltd. Flunixin Meglumine Injection Product Description
11.10.5 Shandong Zhongmu Veterinary Medicine Co., Ltd. Recent Developments
11.11 Hebei New Century Pharmaceutical Co., Ltd.
11.11.1 Hebei New Century Pharmaceutical Co., Ltd. Corporation Information
11.11.2 Hebei New Century Pharmaceutical Co., Ltd. Overview
11.11.3 Hebei New Century Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.11.4 Hebei New Century Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product Description
11.11.5 Hebei New Century Pharmaceutical Co., Ltd. Recent Developments
11.12 Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd.
11.12.1 Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Corporation Information
11.12.2 Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Overview
11.12.3 Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.12.4 Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product Description
11.12.5 Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Recent Developments
11.13 Shandong Lukang Pharmaceutical Co., Ltd.
11.13.1 Shandong Lukang Pharmaceutical Co., Ltd. Corporation Information
11.13.2 Shandong Lukang Pharmaceutical Co., Ltd. Overview
11.13.3 Shandong Lukang Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.13.4 Shandong Lukang Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product Description
11.13.5 Shandong Lukang Pharmaceutical Co., Ltd. Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Flunixin Meglumine Injection Value Chain Analysis
12.2 Flunixin Meglumine Injection Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Flunixin Meglumine Injection Production Mode & Process
12.4 Flunixin Meglumine Injection Sales and Marketing
12.4.1 Flunixin Meglumine Injection Sales Channels
12.4.2 Flunixin Meglumine Injection Distributors
12.5 Flunixin Meglumine Injection Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Flunixin Meglumine Injection Industry Trends
13.2 Flunixin Meglumine Injection Market Drivers
13.3 Flunixin Meglumine Injection Market Challenges
13.4 Flunixin Meglumine Injection Market Restraints
14 Key Findings in The Global Flunixin Meglumine Injection Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Table 1. Global Flunixin Meglumine Injection Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of 10ml/Dose
Table 3. Major Manufacturers of 20ml/ Dose
Table 4. Global Flunixin Meglumine Injection Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
Table 5. Global Flunixin Meglumine Injection Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 6. Global Flunixin Meglumine Injection Sales by Region (2016-2021) & (K Doses)
Table 7. Global Flunixin Meglumine Injection Sales Market Share by Region (2016-2021)
Table 8. Global Flunixin Meglumine Injection Sales by Region (2022-2027) & (K Doses)
Table 9. Global Flunixin Meglumine Injection Sales Market Share by Region (2022-2027)
Table 10. Global Flunixin Meglumine Injection Revenue by Region (2016-2021) & (US$ Million)
Table 11. Global Flunixin Meglumine Injection Revenue Market Share by Region (2016-2021)
Table 12. Global Flunixin Meglumine Injection Revenue by Region (2022-2027) & (US$ Million)
Table 13. Global Flunixin Meglumine Injection Revenue Market Share by Region (2022-2027)
Table 14. Global Flunixin Meglumine Injection Sales by Manufacturers (2016-2021) & (K Doses)
Table 15. Global Flunixin Meglumine Injection Sales Share by Manufacturers (2016-2021)
Table 16. Global Flunixin Meglumine Injection Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 17. Global Flunixin Meglumine Injection Revenue Share by Manufacturers (2016-2021)
Table 18. Flunixin Meglumine Injection Price by Manufacturers 2016-2021 (US$/Dose)
Table 19. Global Flunixin Meglumine Injection Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Flunixin Meglumine Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Flunixin Meglumine Injection as of 2020)
Table 21. Flunixin Meglumine Injection Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Flunixin Meglumine Injection Product Offered
Table 23. Date of Manufacturers Enter into Flunixin Meglumine Injection Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Flunixin Meglumine Injection Sales by Type (2016-2021) & (K Doses)
Table 26. Global Flunixin Meglumine Injection Sales by Type (2022-2027) & (K Doses)
Table 27. Global Flunixin Meglumine Injection Sales Share by Type (2016-2021)
Table 28. Global Flunixin Meglumine Injection Sales Share by Type (2022-2027)
Table 29. Global Flunixin Meglumine Injection Revenue by Type (2016-2021) & (US$ Million)
Table 30. Global Flunixin Meglumine Injection Revenue by Type (2022-2027) & (US$ Million)
Table 31. Global Flunixin Meglumine Injection Revenue Share by Type (2016-2021)
Table 32. Global Flunixin Meglumine Injection Revenue Share by Type (2022-2027)
Table 33. Flunixin Meglumine Injection Price by Type (2016-2021) & (US$/Dose)
Table 34. Global Flunixin Meglumine Injection Price Forecast by Type (2022-2027) & (US$/Dose)
Table 35. Global Flunixin Meglumine Injection Sales by Application (2016-2021) & (K Doses)
Table 36. Global Flunixin Meglumine Injection Sales by Application (2022-2027) & (K Doses)
Table 37. Global Flunixin Meglumine Injection Sales Share by Application (2016-2021)
Table 38. Global Flunixin Meglumine Injection Sales Share by Application (2022-2027)
Table 39. Global Flunixin Meglumine Injection Revenue by Application (2016-2021) & (US$ Million)
Table 40. Global Flunixin Meglumine Injection Revenue by Application (2022-2027) & (US$ Million)
Table 41. Global Flunixin Meglumine Injection Revenue Share by Application (2016-2021)
Table 42. Global Flunixin Meglumine Injection Revenue Share by Application (2022-2027)
Table 43. Flunixin Meglumine Injection Price by Application (2016-2021) & (US$/Dose)
Table 44. Global Flunixin Meglumine Injection Price Forecast by Application (2022-2027) & (US$/Dose)
Table 45. North America Flunixin Meglumine Injection Sales by Type (2016-2021) & (K Doses)
Table 46. North America Flunixin Meglumine Injection Sales by Type (2022-2027) & (K Doses)
Table 47. North America Flunixin Meglumine Injection Revenue by Type (2016-2021) & (US$ Million)
Table 48. North America Flunixin Meglumine Injection Revenue by Type (2022-2027) & (US$ Million)
Table 49. North America Flunixin Meglumine Injection Sales by Application (2016-2021) & (K Doses)
Table 50. North America Flunixin Meglumine Injection Sales by Application (2022-2027) & (K Doses)
Table 51. North America Flunixin Meglumine Injection Revenue by Application (2016-2021) & (US$ Million)
Table 52. North America Flunixin Meglumine Injection Revenue by Application (2022-2027) & (US$ Million)
Table 53. North America Flunixin Meglumine Injection Sales by Country (2016-2021) & (K Doses)
Table 54. North America Flunixin Meglumine Injection Sales by Country (2022-2027) & (K Doses)
Table 55. North America Flunixin Meglumine Injection Revenue by Country (2016-2021) & (US$ Million)
Table 56. North America Flunixin Meglumine Injection Revenue by Country (2022-2027) & (US$ Million)
Table 57. Europe Flunixin Meglumine Injection Sales by Type (2016-2021) & (K Doses)
Table 58. Europe Flunixin Meglumine Injection Sales by Type (2022-2027) & (K Doses)
Table 59. Europe Flunixin Meglumine Injection Revenue by Type (2016-2021) & (US$ Million)
Table 60. Europe Flunixin Meglumine Injection Revenue by Type (2022-2027) & (US$ Million)
Table 61. Europe Flunixin Meglumine Injection Sales by Application (2016-2021) & (K Doses)
Table 62. Europe Flunixin Meglumine Injection Sales by Application (2022-2027) & (K Doses)
Table 63. Europe Flunixin Meglumine Injection Revenue by Application (2016-2021) & (US$ Million)
Table 64. Europe Flunixin Meglumine Injection Revenue by Application (2022-2027) & (US$ Million)
Table 65. Europe Flunixin Meglumine Injection Sales by Country (2016-2021) & (K Doses)
Table 66. Europe Flunixin Meglumine Injection Sales by Country (2022-2027) & (K Doses)
Table 67. Europe Flunixin Meglumine Injection Revenue by Country (2016-2021) & (US$ Million)
Table 68. Europe Flunixin Meglumine Injection Revenue by Country (2022-2027) & (US$ Million)
Table 69. Asia Pacific Flunixin Meglumine Injection Sales by Type (2016-2021) & (K Doses)
Table 70. Asia Pacific Flunixin Meglumine Injection Sales by Type (2022-2027) & (K Doses)
Table 71. Asia Pacific Flunixin Meglumine Injection Revenue by Type (2016-2021) & (US$ Million)
Table 72. Asia Pacific Flunixin Meglumine Injection Revenue by Type (2022-2027) & (US$ Million)
Table 73. Asia Pacific Flunixin Meglumine Injection Sales by Application (2016-2021) & (K Doses)
Table 74. Asia Pacific Flunixin Meglumine Injection Sales by Application (2022-2027) & (K Doses)
Table 75. Asia Pacific Flunixin Meglumine Injection Revenue by Application (2016-2021) & (US$ Million)
Table 76. Asia Pacific Flunixin Meglumine Injection Revenue by Application (2022-2027) & (US$ Million)
Table 77. Asia Pacific Flunixin Meglumine Injection Sales by Region (2016-2021) & (K Doses)
Table 78. Asia Pacific Flunixin Meglumine Injection Sales by Region (2022-2027) & (K Doses)
Table 79. Asia Pacific Flunixin Meglumine Injection Revenue by Region (2016-2021) & (US$ Million)
Table 80. Asia Pacific Flunixin Meglumine Injection Revenue by Region (2022-2027) & (US$ Million)
Table 81. Latin America Flunixin Meglumine Injection Sales by Type (2016-2021) & (K Doses)
Table 82. Latin America Flunixin Meglumine Injection Sales by Type (2022-2027) & (K Doses)
Table 83. Latin America Flunixin Meglumine Injection Revenue by Type (2016-2021) & (US$ Million)
Table 84. Latin America Flunixin Meglumine Injection Revenue by Type (2022-2027) & (US$ Million)
Table 85. Latin America Flunixin Meglumine Injection Sales by Application (2016-2021) & (K Doses)
Table 86. Latin America Flunixin Meglumine Injection Sales by Application (2022-2027) & (K Doses)
Table 87. Latin America Flunixin Meglumine Injection Revenue by Application (2016-2021) & (US$ Million)
Table 88. Latin America Flunixin Meglumine Injection Revenue by Application (2022-2027) & (US$ Million)
Table 89. Latin America Flunixin Meglumine Injection Sales by Country (2016-2021) & (K Doses)
Table 90. Latin America Flunixin Meglumine Injection Sales by Country (2022-2027) & (K Doses)
Table 91. Latin America Flunixin Meglumine Injection Revenue by Country (2016-2021) & (US$ Million)
Table 92. Latin America Flunixin Meglumine Injection Revenue by Country (2022-2027) & (US$ Million)
Table 93. Middle East and Africa Flunixin Meglumine Injection Sales by Type (2016-2021) & (K Doses)
Table 94. Middle East and Africa Flunixin Meglumine Injection Sales by Type (2022-2027) & (K Doses)
Table 95. Middle East and Africa Flunixin Meglumine Injection Revenue by Type (2016-2021) & (US$ Million)
Table 96. Middle East and Africa Flunixin Meglumine Injection Revenue by Type (2022-2027) & (US$ Million)
Table 97. Middle East and Africa Flunixin Meglumine Injection Sales by Application (2016-2021) & (K Doses)
Table 98. Middle East and Africa Flunixin Meglumine Injection Sales by Application (2022-2027) & (K Doses)
Table 99. Middle East and Africa Flunixin Meglumine Injection Revenue by Application (2016-2021) & (US$ Million)
Table 100. Middle East and Africa Flunixin Meglumine Injection Revenue by Application (2022-2027) & (US$ Million)
Table 101. Middle East and Africa Flunixin Meglumine Injection Sales by Country (2016-2021) & (K Doses)
Table 102. Middle East and Africa Flunixin Meglumine Injection Sales by Country (2022-2027) & (K Doses)
Table 103. Middle East and Africa Flunixin Meglumine Injection Revenue by Country (2016-2021) & (US$ Million)
Table 104. Middle East and Africa Flunixin Meglumine Injection Revenue by Country (2022-2027) & (US$ Million)
Table 105. Norbrook Corporation Information
Table 106. Norbrook Description and Major Businesses
Table 107. Norbrook Flunixin Meglumine Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 108. Norbrook Flunixin Meglumine Injection Product
Table 109. Norbrook Recent Developments
Table 110. Zoteis Corporation Information
Table 111. Zoteis Description and Major Businesses
Table 112. Zoteis Flunixin Meglumine Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 113. Zoteis Flunixin Meglumine Injection Product
Table 114. Zoteis Recent Developments
Table 115. Merck Animal Health Corporation Information
Table 116. Merck Animal Health Description and Major Businesses
Table 117. Merck Animal Health Flunixin Meglumine Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 118. Merck Animal Health Flunixin Meglumine Injection Product
Table 119. Merck Animal Health Recent Developments
Table 120. Virbac Animal Health India Private Limited Corporation Information
Table 121. Virbac Animal Health India Private Limited Description and Major Businesses
Table 122. Virbac Animal Health India Private Limited Flunixin Meglumine Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 123. Virbac Animal Health India Private Limited Flunixin Meglumine Injection Product
Table 124. Virbac Animal Health India Private Limited Recent Developments
Table 125. MSD Animal Health Corporation Information
Table 126. MSD Animal Health Description and Major Businesses
Table 127. MSD Animal Health Flunixin Meglumine Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 128. MSD Animal Health Flunixin Meglumine Injection Product
Table 129. MSD Animal Health Recent Developments
Table 130. Bengal Remedies Limited Corporation Information
Table 131. Bengal Remedies Limited Description and Major Businesses
Table 132. Bengal Remedies Limited Flunixin Meglumine Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 133. Bengal Remedies Limited Flunixin Meglumine Injection Product
Table 134. Bengal Remedies Limited Recent Developments
Table 135. Wuhan Huisheng Biological Technology Co., Ltd. Corporation Information
Table 136. Wuhan Huisheng Biological Technology Co., Ltd. Description and Major Businesses
Table 137. Wuhan Huisheng Biological Technology Co., Ltd. Flunixin Meglumine Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 138. Wuhan Huisheng Biological Technology Co., Ltd. Flunixin Meglumine Injection Product
Table 139. Wuhan Huisheng Biological Technology Co., Ltd. Recent Developments
Table 140. Qilu Animal Health Products Co., Ltd. Corporation Information
Table 141. Qilu Animal Health Products Co., Ltd. Description and Major Businesses
Table 142. Qilu Animal Health Products Co., Ltd. Flunixin Meglumine Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 143. Qilu Animal Health Products Co., Ltd. Flunixin Meglumine Injection Product
Table 144. Qilu Animal Health Products Co., Ltd. Recent Developments
Table 145. Baimukang Animal Pharmaceutical Co., Ltd. Corporation Information
Table 146. Baimukang Animal Pharmaceutical Co., Ltd. Description and Major Businesses
Table 147. Baimukang Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 148. Baimukang Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product
Table 149. Baimukang Animal Pharmaceutical Co., Ltd. Recent Developments
Table 150. Shandong Zhongmu Veterinary Medicine Co., Ltd. Corporation Information
Table 151. Shandong Zhongmu Veterinary Medicine Co., Ltd. Description and Major Businesses
Table 152. Shandong Zhongmu Veterinary Medicine Co., Ltd. Flunixin Meglumine Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 153. Shandong Zhongmu Veterinary Medicine Co., Ltd. Flunixin Meglumine Injection Product
Table 154. Shandong Zhongmu Veterinary Medicine Co., Ltd. Recent Developments
Table 155. Hebei New Century Pharmaceutical Co., Ltd. Corporation Information
Table 156. Hebei New Century Pharmaceutical Co., Ltd. Description and Major Businesses
Table 157. Hebei New Century Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 158. Hebei New Century Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product
Table 159. Hebei New Century Pharmaceutical Co., Ltd. Recent Developments
Table 160. Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Corporation Information
Table 161. Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Description and Major Businesses
Table 162. Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 163. Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product
Table 164. Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Recent Developments
Table 165. Shandong Lukang Pharmaceutical Co., Ltd. Corporation Information
Table 166. Shandong Lukang Pharmaceutical Co., Ltd. Description and Major Businesses
Table 167. Shandong Lukang Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 168. Shandong Lukang Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product
Table 169. Shandong Lukang Pharmaceutical Co., Ltd. Recent Developments
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. Flunixin Meglumine Injection Distributors List
Table 173. Flunixin Meglumine Injection Customers List
Table 174. Flunixin Meglumine Injection Market Trends
Table 175. Flunixin Meglumine Injection Market Drivers
Table 176. Flunixin Meglumine Injection Market Challenges
Table 177. Flunixin Meglumine Injection Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
List of Figures
Figure 1. Flunixin Meglumine Injection Product Picture
Figure 2. Global Flunixin Meglumine Injection Market Share by Type in 2020 & 2027
Figure 3. 10ml/Dose Product Picture
Figure 4. 20ml/ Dose Product Picture
Figure 5. Global Flunixin Meglumine Injection Market Share by Application in 2020 & 2027
Figure 6. Animal muscle pain
Figure 7. Animal febrile disease
Figure 8. Others
Figure 9. Flunixin Meglumine Injection Report Years Considered
Figure 10. Global Flunixin Meglumine Injection Sales 2016-2027 (K Doses)
Figure 11. Global Flunixin Meglumine Injection Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Flunixin Meglumine Injection Revenue 2016-2027 (US$ Million)
Figure 13. Global Flunixin Meglumine Injection Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 14. Global Flunixin Meglumine Injection Sales Market Share by Region (2016-2021)
Figure 15. Global Flunixin Meglumine Injection Sales Market Share by Region (2022-2027)
Figure 16. North America Flunixin Meglumine Injection Sales YoY (2016-2027) & (K Doses)
Figure 17. North America Flunixin Meglumine Injection Revenue YoY (2016-2027) & (US$ Million)
Figure 18. Europe Flunixin Meglumine Injection Sales YoY (2016-2027) & (K Doses)
Figure 19. Europe Flunixin Meglumine Injection Revenue YoY (2016-2027) & (US$ Million)
Figure 20. Asia-Pacific Flunixin Meglumine Injection Sales YoY (2016-2027) & (K Doses)
Figure 21. Asia-Pacific Flunixin Meglumine Injection Revenue YoY (2016-2027) & (US$ Million)
Figure 22. Latin America Flunixin Meglumine Injection Sales YoY (2016-2027) & (K Doses)
Figure 23. Latin America Flunixin Meglumine Injection Revenue YoY (2016-2027) & (US$ Million)
Figure 24. Middle East & Africa Flunixin Meglumine Injection Sales YoY (2016-2027) & (K Doses)
Figure 25. Middle East & Africa Flunixin Meglumine Injection Revenue YoY (2016-2027) & (US$ Million)
Figure 26. The Top 10 and Top 5 Players Market Share by Flunixin Meglumine Injection Sales in 2020
Figure 27. The Top 10 and Top 5 Players Market Share by Flunixin Meglumine Injection Revenue in 2020
Figure 28. Flunixin Meglumine Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 29. Global Flunixin Meglumine Injection Sales Market Share by Type (2016-2027)
Figure 30. Global Flunixin Meglumine Injection Revenue Market Share by Type (2016-2027)
Figure 31. Global Flunixin Meglumine Injection Sales Market Share by Application (2016-2027)
Figure 32. Global Flunixin Meglumine Injection Revenue Market Share by Application (2016-2027)
Figure 33. North America Flunixin Meglumine Injection Sales Market Share by Type (2016-2027)
Figure 34. North America Flunixin Meglumine Injection Revenue Market Share by Type (2016-2027)
Figure 35. North America Flunixin Meglumine Injection Sales Market Share by Application (2016-2027)
Figure 36. North America Flunixin Meglumine Injection Revenue Market Share by Application (2016-2027)
Figure 37. North America Flunixin Meglumine Injection Sales Share by Country (2016-2027)
Figure 38. North America Flunixin Meglumine Injection Revenue Share by Country (2016-2027)
Figure 39. United States Flunixin Meglumine Injection Revenue (2016-2027) & (US$ Million)
Figure 40. Canada Flunixin Meglumine Injection Revenue (2016-2027) & (US$ Million)
Figure 41. Europe Flunixin Meglumine Injection Sales Market Share by Type (2016-2027)
Figure 42. Europe Flunixin Meglumine Injection Revenue Market Share by Type (2016-2027)
Figure 43. Europe Flunixin Meglumine Injection Sales Market Share by Application (2016-2027)
Figure 44. Europe Flunixin Meglumine Injection Revenue Market Share by Application (2016-2027)
Figure 45. Europe Flunixin Meglumine Injection Sales Share by Country (2016-2027)
Figure 46. Europe Flunixin Meglumine Injection Revenue Share by Country (2016-2027)
Figure 47. Germany Flunixin Meglumine Injection Revenue (2016-2027) & (US$ Million)
Figure 48. France Flunixin Meglumine Injection Revenue (2016-2027) & (US$ Million)
Figure 49. U.K. Flunixin Meglumine Injection Revenue (2016-2027) & (US$ Million)
Figure 50. Italy Flunixin Meglumine Injection Revenue (2016-2027) & (US$ Million)
Figure 51. Russia Flunixin Meglumine Injection Revenue (2016-2027) & (US$ Million)
Figure 52. Asia Pacific Flunixin Meglumine Injection Sales Market Share by Type (2016-2027)
Figure 53. Asia Pacific Flunixin Meglumine Injection Revenue Market Share by Type (2016-2027)
Figure 54. Asia Pacific Flunixin Meglumine Injection Sales Market Share by Application (2016-2027)
Figure 55. Asia Pacific Flunixin Meglumine Injection Revenue Market Share by Application (2016-2027)
Figure 56. Asia Pacific Flunixin Meglumine Injection Sales Share by Region (2016-2027)
Figure 57. Asia Pacific Flunixin Meglumine Injection Revenue Share by Region (2016-2027)
Figure 58. China Flunixin Meglumine Injection Revenue (2016-2027) & (US$ Million)
Figure 59. Japan Flunixin Meglumine Injection Revenue (2016-2027) & (US$ Million)
Figure 60. South Korea Flunixin Meglumine Injection Revenue (2016-2027) & (US$ Million)
Figure 61. India Flunixin Meglumine Injection Revenue (2016-2027) & (US$ Million)
Figure 62. Australia Flunixin Meglumine Injection Revenue (2016-2027) & (US$ Million)
Figure 63. China Taiwan Flunixin Meglumine Injection Revenue (2016-2027) & (US$ Million)
Figure 64. Indonesia Flunixin Meglumine Injection Revenue (2016-2027) & (US$ Million)
Figure 65. Thailand Flunixin Meglumine Injection Revenue (2016-2027) & (US$ Million)
Figure 66. Malaysia Flunixin Meglumine Injection Revenue (2016-2027) & (US$ Million)
Figure 67. Latin America Flunixin Meglumine Injection Sales Market Share by Type (2016-2027)
Figure 68. Latin America Flunixin Meglumine Injection Revenue Market Share by Type (2016-2027)
Figure 69. Latin America Flunixin Meglumine Injection Sales Market Share by Application (2016-2027)
Figure 70. Latin America Flunixin Meglumine Injection Revenue Market Share by Application (2016-2027)
Figure 71. Latin America Flunixin Meglumine Injection Sales Share by Country (2016-2027)
Figure 72. Latin America Flunixin Meglumine Injection Revenue Share by Country (2016-2027)
Figure 73. Mexico Flunixin Meglumine Injection Revenue (2016-2027) & (US$ Million)
Figure 74. Brazil Flunixin Meglumine Injection Revenue (2016-2027) & (US$ Million)
Figure 75. Argentina Flunixin Meglumine Injection Revenue (2016-2027) & (US$ Million)
Figure 76. Middle East and Africa Flunixin Meglumine Injection Sales Market Share by Type (2016-2027)
Figure 77. Middle East and Africa Flunixin Meglumine Injection Revenue Market Share by Type (2016-2027)
Figure 78. Middle East and Africa Flunixin Meglumine Injection Sales Market Share by Application (2016-2027)
Figure 79. Middle East and Africa Flunixin Meglumine Injection Revenue Market Share by Application (2016-2027)
Figure 80. Middle East and Africa Flunixin Meglumine Injection Sales Share by Country (2016-2027)
Figure 81. Middle East and Africa Flunixin Meglumine Injection Revenue Share by Country (2016-2027)
Figure 82. Turkey Flunixin Meglumine Injection Revenue (2016-2027) & (US$ Million)
Figure 83. Saudi Arabia Flunixin Meglumine Injection Revenue (2016-2027) & (US$ Million)
Figure 84. UAE Flunixin Meglumine Injection Revenue (2016-2027) & (US$ Million)
Figure 85. Flunixin Meglumine Injection Value Chain
Figure 86. Flunixin Meglumine Injection Production Process
Figure 87. Channels of Distribution
Figure 88. Distributors Profiles
Figure 89. Bottom-up and Top-down Approaches for This Report
Figure 90. Data Triangulation
Figure 91. Key Executives Interviewed
世界のフルニキシンメグルミン注射市場インサイト・予測（～2027年） Flunixin Meglumine Injection is used for febrile diseases, muscle pain and soft tissue pain of livestock and small animals Market Analysis and Insights: Global Flunixin Meglumine Injection Market The global Flunixin Meglumine Injection market is valued at US$ XX million in 2020. The market size will…- 世界のフルニキシンメグルミンAPI市場インサイト・予測（～2027年） Flunixin Meglumine is an organic compound with the molecular formula C14H11F3N2O2.C7H17NO5, which can relieve inflammation and pain caused by abnormal muscles Market Analysis and Insights: Global Flunixin Meglumine API Market The global Flunixin Meglumine API market is valued at US$ XX million in 20…
- メグルミンの世界及び中国市場 Meglumine is a white crystalline powder. Melting point 128-129°C. Soluble in water, slightly soluble in ethanol, almost insoluble in chloroform. Taste sweet and salty astringent. The molecular formula is C7H17NO5 and the molecular weight is 195.21400. The density is 1.375, the melting point is 128-1…
- 世界のセフキノム硫酸塩注射市場インサイト・予測（～2027年） Cefquinome Sulfate Injection is mainly used for high fever, pneumonia and metritis in dairy cows caused by sensitive bacteria Market Analysis and Insights: Global Cefquinome Sulfate Injection Market The global Cefquinome Sulfate Injection market is valued at US$ XX million in 2020. The market size w…
- 世界のセフチオフル塩酸塩注射市場インサイト・予測（～2027年） Ceftiofur Hydrochloride Injection is used to treat bacterial infections in livestock and poultry, and it can also be used to treat mastitis infections in pigs and cattle. Market Analysis and Insights: Global Ceftiofur Hydrochloride Injection Market The global Ceftiofur Hydrochloride Injection market…